Paradice Investment Management LLC Buys 201,997 Shares of Enhabit, Inc. (NYSE:EHAB)

Paradice Investment Management LLC increased its holdings in shares of Enhabit, Inc. (NYSE:EHAB - Free Report) by 12.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,780,113 shares of the company's stock after purchasing an additional 201,997 shares during the quarter. Enhabit accounts for 2.8% of Paradice Investment Management LLC's holdings, making the stock its 19th biggest position. Paradice Investment Management LLC owned approximately 3.54% of Enhabit worth $13,903,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of EHAB. FMR LLC grew its stake in shares of Enhabit by 138.4% during the 3rd quarter. FMR LLC now owns 3,388 shares of the company's stock worth $27,000 after acquiring an additional 1,967 shares in the last quarter. Gladius Capital Management LP boosted its holdings in shares of Enhabit by 78.2% in the 3rd quarter. Gladius Capital Management LP now owns 6,259 shares of the company's stock valued at $49,000 after buying an additional 2,747 shares during the last quarter. Stoneridge Investment Partners LLC acquired a new stake in shares of Enhabit in the 3rd quarter valued at approximately $81,000. Intech Investment Management LLC acquired a new stake in shares of Enhabit in the 3rd quarter valued at approximately $96,000. Finally, Versor Investments LP acquired a new stake in shares of Enhabit in the 3rd quarter valued at approximately $97,000.

Insider Buying and Selling at Enhabit

In other news, Director Stuart M. Mcguigan bought 15,000 shares of the company's stock in a transaction dated Tuesday, December 10th. The stock was bought at an average price of $8.81 per share, with a total value of $132,150.00. Following the completion of the acquisition, the director now owns 46,810 shares of the company's stock, valued at $412,396.10. This represents a 47.15 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Jeffrey Bolton bought 4,000 shares of the company's stock in a transaction dated Thursday, December 12th. The shares were purchased at an average cost of $8.69 per share, with a total value of $34,760.00. Following the acquisition, the director now directly owns 98,144 shares of the company's stock, valued at approximately $852,871.36. This represents a 4.25 % increase in their position. The disclosure for this purchase can be found here. Insiders own 1.90% of the company's stock.

Enhabit Stock Performance

Enhabit stock traded down $0.31 during mid-day trading on Friday, hitting $8.14. 200,639 shares of the company's stock traded hands, compared to its average volume of 260,504. The firm has a 50 day simple moving average of $8.11 and a two-hundred day simple moving average of $7.92. Enhabit, Inc. has a fifty-two week low of $6.85 and a fifty-two week high of $11.74. The stock has a market cap of $409.06 million, a price-to-earnings ratio of -3.51 and a beta of 1.83. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46.

Analysts Set New Price Targets

Several research firms have recently commented on EHAB. Jefferies Financial Group raised Enhabit from a "hold" rating to a "buy" rating and increased their price objective for the company from $8.25 to $9.50 in a report on Monday, December 9th. Leerink Partners reissued a "market perform" rating and issued a $8.00 price objective (down previously from $8.50) on shares of Enhabit in a report on Tuesday, November 19th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, Enhabit presently has an average rating of "Hold" and an average target price of $8.75.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.